Literature DB >> 24494807

Is familial nonmedullary thyroid carcinoma more aggressive than sporadic nonmedullary thyroid carcinoma?

Carl D Malchoff1, Thomas J McDonald.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24494807     DOI： 10.1089/thy.2013.0694

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  4 in total

1.  RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study.

Authors:  Matteo Landriscina; Maria Iole Natalicchio; Olga Lamacchia; Antonella Conserva; Annamaria Piscazzi; Anna Ciampolillo; Matteo Zingrillo; Antonio Pennella; Pantaleo Bufo; Giulia Vita; Raffaele Antonetti; Eugenio Maiorano; Francesco Giorgino; Mauro Cignarelli
Journal:  Oncol Lett       Date:  2015-06-17       Impact factor: 2.967

2.  Results of Screening in Familial Non-Medullary Thyroid Cancer.

Authors:  Joanna Klubo-Gwiezdzinska; Lily Yang; Roxanne Merkel; Dhaval Patel; Naris Nilubol; Maria J Merino; Monica Skarulis; Samira M Sadowski; Electron Kebebew
Journal:  Thyroid       Date:  2017-07-19       Impact factor: 6.568

Review 3.  The impact of family history on non-medullary thyroid cancer.

Authors:  I J Nixon; C Suárez; R Simo; A Sanabria; P Angelos; A Rinaldo; J P Rodrigo; L P Kowalski; D M Hartl; M L Hinni; J P Shah; A Ferlito
Journal:  Eur J Surg Oncol       Date:  2016-08-11       Impact factor: 4.424

4.  Longer Time to Reach Excellent Response to Treatment in Familial Versus Sporadic Non-medullary Thyroid Cancer (NMTC): A Matched Case-Control Study.

Authors:  Susan Shafiei; Mehrdokht Sadrolodabaei; Atena Aghaei; Narjess Ayati; Samira Zare Namdar; Donya Hemati; Seyed Rasoul Zakavi
Journal:  Int J Endocrinol Metab       Date:  2021-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.